41 rue de Villiers
Key members of our team
Dr Patrick Larcier has over 30 years of experience in understanding non-clinical, clinical and regulatory development. He is experienced in co-developing products in both EU/US regions, conducting Early Access and Compassionate Use Programs, setting and monitoring pre- and post- market vigilance activities
His main focuses: innovative medicines in oncology, auto-immune disorders, and orphan indications.
Valentine Monnier, our jurist with a master’s degree in RA, has experience in analyzing and evaluating documents from the French & European regulatory bases. She ensures daily regulatory monitoring with a specific focus on our customers and participates in the regulatory consulting activities; she is also responsible for organizing ActuPractice seminars.
Mathilde Gaultier-Renouf has over 10 years of experience in drug safety in 2 international pharmaceutical industries (MSD Animal Health and Servier). She has a deep understanding of ICSRs processing, drug safety reports writing, interaction with CAs, involvement in CAs inspections, medical and drug safety training and signal detection.
Marguerite Windsor provides strategic input for market access and maintenance of medicines, MD and food supplements, with a focus on innovative products. She also manages the pricing and reimbursement strategy by coordinating the preparation of the required documentation. Marguerite has been with us for 3 years, she is a jurist with a master’s degree in Health Law and has a PharmD.
Blandine Bourrinet is dedicated to pharmaceutical Responsibility and area of ‘exploitant’ in France; she also gives advices on anti-gift law, transparency and certification of sales representative network. She is responsible for internal/external audits and she is the Head of the French training department (Regulatory & PV)
She is a pharmacist who joined us in 2015, after 15 years in pharmaceutical companies and 7 years in a training organization.
Paul Bolot has experience in various areas. From regulatory review of promotional/non-promotional materials for different pharmaceutical products to regulatory consultancy, regulatory labelling, project management and readability tests management. He worked previously at Bayer Healthcare Pharmaceuticals and Servier as a Regulatory Affairs intern.
Audrey Finesso provides Drug development (included early stage) and RA strategy for SME, biotech and pharmaceutical companies for EU/US. She has experience with Scientific Advices meetings with European Agencies (EMA, ANSM, BfArM), orphan drug designation in Europe and Type B & C meetings with the FDA
Also, she has a strong experience in diseases with unmet medical needs/innovative products.
Véronique Mougeot, throughout her 27 years within Pharmalex, gathered experience in consulting in RA, medical writings of all types such as clinical/nonclinical expertise, clinical variations, open access dossiers, etc. During her career she gained experience in areas such as writing protocols, preparation of MA to regulatory agencies, PK and statistical analysis.
Céline Hocquet-Merlin has over 17 years of experience from process development, to CMC, RA or quality. During the past 8 years among us she gained strong experience in consulting activities, expertise in quality guidelines, variations regulations, pharmaceutical dossiers writing, due-diligence for all pharmaceutical forms, technical and GMP-linked questions (CMC compliance).
Mélanie Alhusban has over 10 years of experience in pharmaceutical industry. In charge of the CMC and RegOPS (publishing, submission, …) units, she has joined us in October 2017. She has participated, amongst other activities, in managing regulatory projects, has prepared and contributed to write and review regulatory documents but also to expand the existing portfolio.
41 rue de Villiers, 92200 Neuilly-sur-Seine